| Elaine Weidenhammer,
Ph.D., Associate Director of Corporate Development at Nanogen Inc.
in San Diego, California, is this year's recipient of the AACC's Sigi
Ziering Award for Outstanding Contribution for a Publication in the
Journal Clinical Chemistry. During four years as a research
scientist at Nanogen, Dr. Weidenhammer developed gene expression and
genotyping applications on the NanoChip® array. She helped
develop novel methodologies for analyzing levels of multiple mRNA
transcripts over multiple time points on a single microarray, an effort
that recently gained a patent. This work was |
 |
|
the topic of
the winning paper, "Multiplexed, Targeted Gene Expression Profiling
and Genetic Analysis on Electronic Microarrays" (Clin Chem 2002;48:1873-82),
coauthored by Brenda F. Kahl, Ling Wang, Larry Wang, Melanie Duhon,
Jo Ann Jackson, Matthew Slater and Xiao Xu.
Dr. Weidenhammer
currently provides technical expertise for corporate development
at Nanogen, coordinates collaboration with external researchers,
and presents the company's technology at scientific workshops and
meetings. She is a member of the AMP, AAAS and AACC, and is currently
serving on the nominating committee of the Molecular Pathology Division
of the AACC. Dr. Weidenhammer is past president of the San Diego
chapter of the Association for Women in Science, and has cochaired
the organizing committee for the Women in Bioscience Conference,
a biannual chapter event attended by more than 350 participants.
The Sigi Ziering
Award is a DPC-sponsored AACC award which recognizes the paper published
in the AACC's journal Clinical Chemistry during the preceding
calendar year that most significantly advances clinical laboratory
science and laboratory medicine.
|
